TG Therapeutics
Utility Patents

Last updated:

List of all TG Therapeutics patents 2 in total

Status Patent
Grant
Utility: Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders External link
Filling date: 7 Sep 2025 Issue date: 6 Apr 2021
Grant
Utility: Combination of anti-CD20 antibody and PI3 kinase selective inhibitor External link
Filling date: 7 Sep 2025 Issue date: 4 Aug 2020

Showing 1 to 2 of 2 patents.